Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

NCT00005808 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

54

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Cervical Cancer
Cervical Intraepithelial Neoplasia Grade 2
Cervical Intraepithelial Neoplasia Grade 3

Interventions

DRUG: motexafin lutetium
DRUG: photodynamic therapy
PROCEDURE: loop electrosurgical excision procedure
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)